>北米の医薬品バイアル市場、材質別（ガラス、プラスチック、その他）、ネックタイプ別（スクリューネック、クリンプネック、ダブルチャンバー、フリップキャップ、その他）、キャップサイズ別（13～425 mm、15～425 mm、18～400 mm、22～350 mm、24～400 mm、8～425 mm、9 mm、その他）、流通チャネル別（直販、医薬品店/薬局、電子商取引、その他）、容量別（1 ml、2 ml、3 ml、4 ml、8 ml、10 ml、20 ml、30 ml、50 ml、その他）、薬剤タイプ別（注射剤および非注射剤）、用途別（経口、経鼻、注射剤、その他）、エンドユーザー別（製薬会社、バイオ医薬品会社、受託開発製造会社、複合薬局、その他）、市場別（非経口、胃腸、耳鼻咽喉その他）、国別（米国、カナダ、メキシコ）の業界動向と2028年までの予測
市場分析と洞察: 北米の医薬品バイアル市場
医薬品バイアル市場は、2021年から2028年の予測期間に市場成長が見込まれています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に6.9％のCAGRで成長し、2028年までに90億739万米ドルに達すると予測しています。
医薬品バイアルは、主に液体、時には液体、カプセル剤の保管に使用される、医薬品の保管に使用される小さなプラスチック製またはガラス製の容器の一種です。医薬品バイアルは、製薬会社、バイオ医薬品会社、複合薬局など、さまざまな分野に存在しています。医薬品バイアルは、プラスチック、ガラス、その他さまざまな材料を使用して製造されています。バイアルは、製品の保存期間と耐久性を高めるのに役立ちます。
いくつかのメーカーは、医薬品の保存期間を延ばすのに役立つ、ガラスやプラスチック材料からの高品質の梱包製品の製造に携わっています。医薬品業界の多層設計の梱包製品は、衝撃を受けてもさらなる完全性を保証します。毒性のある薬剤や高効力の薬剤の梱包では、耐亀裂性と完全性を兼ね備えた梱包製品の需要が医薬品業界で高まっています。
この医薬品バイアル市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。
北米の医薬品バイアル市場の範囲と市場規模
North America pharmaceutical vials market is segmented of the basis into material, neck type, cap size, distribution channel, capacity, drug type, application, end-user and market. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of material, the pharmaceutical vials market is segmented into plastic, glass and others. In 2021, glass is dominating because of the non-leakage properties which are driving pharmaceutical vials market.
- On the basis of neck type, the pharmaceutical vials market is segmented into crimp neck, double chamber, screw neck, flip cap and others. In 2021, Screw neck segment is dominating because of growing application in gastro sector.
- On the basis of cap size, the market is segmented into 13-425 MM, 15-425 MM, 18-400 MM, 22-350 MM, 24-400 MM, 8-425 MM, 9MM and others. In 2021, 9MM is dominating because the processing takes place at large scale due to requirement.
- On the basis of distribution channel, the market is segmented into direct sales, medical stores/pharmacies, e-commerce and others. In 2021, direct sales are dominating because of the huge build relationships with the customers which boost the demand of the pharmaceutical vials market.
- On the basis of capacity, the market is segmented into 1 ML, 2 ML, 3 ML, 4 ML, 8 ML, 10 ML, 20 ML, 30 ML, 50 ML and others. In 2021, 1 ML is dominating because of high efficiency which boosts the demand of the pharmaceutical vials market.
- On the basis of drug type, the market is segmented into injectable and non-injectable. In 2021, Injectable is dominating because of properties which control the dosage consumption amount that maximizes its application.
- On the basis of application, the market is segmented into nasal, oral and others. In 2021, Oral is dominating because of the huge amount of consumption in biopharmaceutical companies.
- On the basis of end-user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract development and manufacturing companies, compound pharmacy and others. In 2021, pharmaceutical companies are dominating because of increasing formation of medicines to treat various diseases that is the reason which boosts the demand of the pharmaceutical vials market.
- On the basis of market, the pharmaceutical vials market is segmented into parenteral, gastro, ENT and others. In 2021, the parenteral segment is dominating because of the features that enhances medication adherence.
Pharmaceutical vials Market Country Level Analysis
North America pharmaceutical vials market is analysed and market size information is provided by material, neck type, cap size, distribution channel, capacity, drug type, application, end-user and market.
The countries covered in the pharmaceutical vials market report are U.S., Canada and Mexico in North America.
北米の医薬品バイアル市場は、この地域の医薬品業界での包装需要の高まりにより、市場を独占しています。医薬品バイアル製品は国内で大量に製造され、消費されているため、米国は医薬品バイアル市場で優位に立っています。また、製品の製造における高度な革新と開発は、国の成長の大きな要因の 1 つです。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響を考慮しながら、国別データの予測分析を提供します。
医薬品バイアル業界の成長
北米の医薬品バイアル市場では、医薬品バイアル市場向けのさまざまな種類の製品のインストールベースの各国の成長、ライフライン曲線を使用したテクノロジーの影響、乳児用調合乳の規制シナリオの変更とそれらが医薬品バイアル市場に与える影響に関する詳細な市場分析も提供されます。データは、2011年から2019年までの履歴期間で利用できます。
競争環境と医薬品バイアル市場シェア分析
北米の医薬品バイアル市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、会社の強みと弱み、製品の発売、臨床試験パイプライン、ブランド分析、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、北米の医薬品バイアル市場に関連する会社の焦点にのみ関連しています。
このレポートで取り上げられている主な企業は、Gerresheimer AG、SCHOTT AG、Berry Global Inc.、West Pharmaceutical Services Inc、Origin Pharma Packaging、SGD Pharma、Pacific Vial Manufacturing Inc.、Bormioli Pharma Spa、TOYOBO CO., LTD.、NIPRO、Piramal Glass Private Limited、Corning Incorporated、DWK Life Sciences Ltd、APG、Stevanato Groupなど、国内外の企業です。DBMRのアナリストは、競争力を理解し、各競合他社の競合分析を個別に提供します。
- 2020年5月、Piramal Glass Private Limited.社は、ガラス包装製品をデジタルガラス製造業者に転換することで事業を展開することを決定しました。この展開は、同社の収益増加に役立ちます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 DRUG TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 VENDOR SHARE ANALYSIS
2.13 IMPORT-EXPORT DATA
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING DEMAND OF PACKAGING IN PHARMACEUTICAL INDUSTRY
5.1.2 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING
5.1.3 GROWTH OF PREFILLED SYRINGES
5.1.4 GROWING HEALTH AWARENESS AND ADOPTION OF NEW TECHNIQUES FOR STORAGE OF LIQUID MEDICINE
5.2 RESTRAINTS
5.2.1 CHEMICALS RELEASE OF THE INTERNAL SURFACE OF GLASS TUBING CONTAINERS
5.2.2 INCREASING COST OF OVERALL PACKAGING
5.3 OPPORTUNITIES
5.3.1 IMPLEMENTING READY-TO USE GLASS VIALS FOR FLEXIBLE ASEPTIC FILLING
5.3.2 INCREASING DEMAND OF PACKAGING FOR COVID-19 VACCINE
5.4 CHALLENGES
5.4.1 RECYCLING OF WASTE PRODUCE BY PHARMACEUTICAL PACKAGING
5.4.2 INCREASING GOVERNMENT REGULATIONS TOWARDS PHARMACEUTICAL SECTOR
6 COVID-19 IMPACT ON THE PHARMACEUTICAL VIALS MARKET IN CHEMICAL AND MATERIALS INDUSTRY
6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET
6.2 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET
6.3 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
6.4 PRICE IMPACT
6.5 IMPACT ON DEMAND
6.6 IMPACT ON SUPPLY CHAIN
6.7 CONCLUSION
7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL
7.1 OVERVIEW
7.2 GLASS
7.2.1 GLASS BY COLOR
7.2.1.1 Amber
7.2.1.2 Clear
7.2.1.3 Others
7.2.2 GLASS BY TYPE
7.2.2.1 TYPE I (Borosilicate Glass)
7.2.2.2 TYPE II (Treated Soda-Lime Glass)
7.2.2.3 TYPE III (Regular Soda Lime Glass)
7.2.2.4 TYPE IV (Type Np Glass/General-Purpose Soda Lime Glass)
7.2.3 GLASS BY PRODUCT
7.2.3.1 Serum / Specialty Glass Vials
7.2.3.2 Screw Thread Glass Vials
7.2.3.3 Sterile Glass Vials
7.2.3.4 Sample Glass Vials
7.2.3.5 Autosampler Vials
7.2.3.6 Chromatography Vials
7.2.3.7 Epa Voa Vials
7.2.3.8 Others
7.3 PLASTIC
7.3.1 PLASTIC BY COLOR
7.3.1.1 Translucent
7.3.1.2 Opaque
7.3.1.3 Others
7.3.2 PLASTIC BY TYPE
7.3.2.1 High-density polyethylene (HDPE)
7.3.2.2 Polystyrene
7.3.2.3 Polypropylene
7.3.2.4 Polyvinyl Chloride (PVC)
7.3.2.5 Polycarbonate
7.3.2.6 Polyester
7.3.2.7 Others
7.4 OTHERS
8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE
8.1 OVERVIEW
8.2 SCREW NECK
8.3 CRIMP NECK
8.4 DOUBLE CHAMBER
8.5 FLIP CAP
8.6 OTHERS
9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE
9.1 OVERVIEW
9.2 9MM
9.3 8-425 MM
9.4 13-425 MM
9.5 15-425 MM
9.6 18-400 MM
9.7 22-350 MM
9.8 24-400 MM
9.9 OTHERS
10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT SALES
10.3 MEDICAL STORES/PHARMACIES
10.4 E-COMMERCE
10.5 OTHERS
11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY
11.1 OVERVIEW
11.2 1 ML
11.3 2 ML
11.4 3 ML
11.5 4 ML
11.6 8 ML
11.7 10 ML
11.8 20 ML
11.9 30 ML
11.1 50 ML
11.11 OTHERS
12 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE
12.1 OVERVIEW
12.2 INJECTABLE
12.2.1 INJECTABLE TYPE
12.2.1.1 Lyophilized
12.2.1.2 Liquid
12.3 NON-INJECTABLE
12.3.1 NON-INJECTABLE TYPE
12.3.1.1 Diagnostic
12.3.1.2 Solid
13 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 ORAL
13.3 NASAL
13.4 OTHERS
14 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER
14.1 OVERVIEW
14.2 PHARMACEUTICAL COMPANIES
14.3 BIOPHARMACEUTICAL COMPANIES
14.4 CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES
14.5 COMPOUND PHARMACY
14.6 OTHERS
15 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET
15.1 OVERVIEW
15.2 PARENTERAL
15.3 GASTRO
15.4 ENT
15.5 OTHERS
16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY GEOGRAPHY
16.1 OVERVIEW
16.2 NORTH AMERICA
16.2.1 U.S.
16.2.2 CANADA
16.2.3 MEXICO
17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17.2 MERGERS & ACQUISITIONS
17.3 EXPANSIONS
17.4 NEW PRODUCT DEVELOPMENT
18 SWOT ANALYSIS
19 COMPANY PROFILES
19.1 BERRY NORTH AMERICA INC.
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT UPDATE
19.2 WEST PHARMACEUTICAL SERVICES, INC.
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT UPDATE
19.3 PIRAMAL GLASS PRIVATE LIMITED (A SUBSIDIARY OF PIRAMAL ENTERPRISES LTD.)
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT UPDATE
19.4 TOYOBO CO., LTD.
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT UPDATE
19.5 CORNING INCORPORATED
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT UPDATES
19.6 GERRESHEIMER AG
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT UPDATE
19.7 NIPRO
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT UPDATE
19.8 SCHOTT AG
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT UPDATE
19.9 APG
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT UPDATE
19.1 BORMIOLI PHARMA S.P.A.
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT UPDATE
19.11 DWK LIFE SCIENCES LTD.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT UPDATE
19.12 ORIGIN PHARMA PACKAGING
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT UPDATE
19.13 PACIFIC VIAL
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT UPDATE
19.14 SGD PHARMA (A SUBSIDIARY OF SAINT-GOBAIN)
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT UPDATE
19.15 STEVANATO GROUP
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT UPDATE
20 QUESTIONNAIRE
21 RELATED REPORTS
表のリスト
LIST OF TABLES
TABLE 1 IMPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 2 EXPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 3 TIME TAKEN FOR GARBAGE TO DECOMPOSE IN THE ENVIRONMENT (2015)
TABLE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY TYPE, 2019-2028 (MILLION UNITS)
TABLE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY REGION, 2019-2028 (MILLION UNITS)
TABLE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY REGION, 2019-2028 (MILLION UNITS)
TABLE 13 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (MILLION UNITS)
TABLE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, SCREW NECK BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, CRIMP NECK BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, DOUBLE CHAMBER BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, FLIP CAP BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 9MM BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 8-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 13-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 15-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 18-400 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 22-350 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 24-400 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, DIRECT SALES BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, MEDICAL STORES/PHARMACIES BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, E-COMMERCE BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 1 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 2 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 3 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 4 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 8 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 10 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 20 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 30 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 50 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, INJECTABLE BY REGION, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY INJECTABLE TYPE, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, NON-INJECTABLE BY REGION, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NON-INJECTABLE TYPE, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, ORAL BY REGION, 2019-2028 (USD MILLION)
TABLE 55 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, NASAL BY REGION, 2019-2028 (USD MILLION)
TABLE 56 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 57 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER, 2019-2028 (USD MILLION)
TABLE 58 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PHARMACEUTICAL COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 59 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BIOPHARMACEUTICAL COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 60 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 61 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, COMPOUND PHARMACY BY REGION, 2019-2028 (USD MILLION)
TABLE 62 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 63 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET, 2019-2028 (USD MILLION)
TABLE 64 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PARENTERAL BY REGION, 2019-2028 (USD MILLION)
TABLE 65 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GASTRO BY REGION, 2019-2028 (USD MILLION)
TABLE 66 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, ENT BY REGION, 2019-2028 (USD MILLION)
TABLE 67 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 69 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY REGION, 2018-2027 (MILLION UNITS)
TABLE 70 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 71 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY COUNTRY ,2019-2028 (USD MILLION)
TABLE 72 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY COUNTRY ,2019-2028 (MILLION UNITS)
TABLE 73 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 74 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 75 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 76 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 78 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 79 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 80 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 81 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 82 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 83 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 84 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 85 NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 86 NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 87 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 88 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 89 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 90 U.S. PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 91 U.S. PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 92 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 93 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 94 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 95 U.S. PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 96 U.S. PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 97 U.S. PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 98 U.S. PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 99 U.S. PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 100 U.S. PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 101 U.S. PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 102 U.S. PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 103 U.S. PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 104 U.S. PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 105 U.S. PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 106 U.S. PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 107 CANADA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 108 CANADA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 109 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 110 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 111 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 112 CANADA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 113 CANADA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 114 CANADA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 115 CANADA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 116 CANADA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 117 CANADA PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 118 CANADA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 119 CANADA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 120 CANADA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 121 CANADA PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 122 CANADA PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 123 CANADA PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 124 MEXICO PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 125 MEXICO PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 126 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 127 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 129 MEXICO PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 130 MEXICO PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 131 MEXICO PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 132 MEXICO PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 133 MEXICO PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 134 MEXICO PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 135 MEXICO PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 136 MEXICO PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 137 MEXICO PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 138 MEXICO PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 139 MEXICO PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 140 MEXICO PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
図表一覧
LIST OF FIGURES
FIGURE 1 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE DRUG TYPE LIFE LINE CURVE
FIGURE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION
FIGURE 12 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING IS DRIVING THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GLASS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR PHARMACEUTICAL VIALS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET
FIGURE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL, 2020
FIGURE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY NECK TYPE, 2020
FIGURE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAP SIZE, 2020
FIGURE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAPACITY, 2020
FIGURE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DRUG TYPE, 2020
FIGURE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY APPLICATION, 2020
FIGURE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY END-USER, 2020
FIGURE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MARKET, 2020
FIGURE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2019)
FIGURE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019)
FIGURE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2020 & 2027)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019 & 2027)
FIGURE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2020-2027)
FIGURE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2020)
FIGURE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020)
FIGURE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2021-2028)
FIGURE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY SHARE 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
